An Australian stem cell and regenerative medicine company

April 23, 2021

Cynata’s Cymerus™ MSCs featured in Channel 9 news article on the SCUlpTOR Phase 3 Clinical Trial in Osteoarthritis

Channel 9 Health Reporter Gabriella Rogers explores the potential therapeutic benefits of Cynata’s MSC product in this serious disease and reviews the SCULpTOR trial with Professor David Hunter

Read Article

March 25, 2021

Guest Column by Ross Macdonald in Leading Industry Newsletter “Cell & Gene”

Addressing The Challenges Of MSCs Will Reveal A Bright Future For This Regenerative Medicine Modality.

Show full article

March 10, 2021

Women to Watch

Celebrating Fantastic Women in Regenerative Medicine: An Interview With Cynata’s Dr Suzanne Lipe, Vice President of Partner Engagement.

Read More at RegMedNet

January 20, 2021

Interview with Ross Macdonald

Jessica Allen of the Market Herald speaks with Dr Ross Macdonald about Cynata's recent successful capital raise and the Company’s plans to deploy the additional funds.

Watch the video on

(Timecode 8:29)

November 20, 2020

Interview with Ross Macdonald

Stuart Roberts, respected analyst and industry commentator at Pitt Street Research speaks with Dr Ross Macdonald about Cynata's market position, research and clinical trials.

Interview with Dr Ross MacDonald, CEO Cynata Therapeutics (ASX:CYP) 20 November 2020 from Pitt Street Research on Vimeo.